Biostatistics

Print this page Create a PDFShare this page
Send to a friend

"We know that sound statistical advice will save both costs and time."

 

Business & Decision Life Sciences provides comprehensive biostatistics and statistical programming services to support clinical, pre-clinical, epidemiology, health economics, and patient-reported outcomes for pharmaceutical, medical devices, and biologicals companies.

Services include the delivery of extra resources to support the biostatistics and clinical programming departments, management consulting, expert biostatistical consulting, the development of customized biostatistical applications, conversion of legacy clinical trial data to the ADaM (CDISC) standards as well as end-to-end biostatistical analysis services for clinical, epidemiological and pre-clinical studies.

Key Areas

Business & Decision Life Sciences can provide biostatistics and clinical programming support in the following areas:

  • Trial design
  • Sample size and power calculations
  • Statistical protocol development
  • Statistical programming including creation of derived data sets and creation of displays, listings and graphical presentations
  • Statistical automation
  • Statistical analysis plan writing
  • Statistical and clinical report writing
  • Statistical support to Data and Safety Monitoring Boards (DSMBs)
  • Pooled analyses for summaries of clinical safety (SCS; formerly ISS) and efficacy (SCE; formerly ISE)
  • Writing of SCS and SCE
  • Conversion of legacy data to the ADaM and SDTM standards
  • Data mining

Biostatistics Solutions

Business & Decision Life Sciences has a long standing track record of providing biostatistical and clinical programming services to the life sciences industry. Business & Decision combine the technical knowledge of biostatistics, complex statistical modeling and knowledge of statistical software tools (SAS, S+, R, ...) with a broad experience of the business processes and regulatory requirements of the life sciences industry.

  • follow us on
  • Twitter
  • Linked In